Video

Anna Vioral on Multidisciplinary Chemotherapy Safety Standards

Anna Vioral, RN, OCN, from West Penn Allegheny Health System, on Multidisciplinary Chemotherapy Safety Standards.

Anna Vioral, MSN, MEd, RN, OCN®, Oncology, West Penn Allegheny Health System, summarizes a three year effort to standardize and integrate a set of multidisciplinary chemotherapy safety standards, which used the preexisting recommendations from the American Society of Clinical Oncology (ASCO) and Oncology Nursing Society (ONS).

Vioral notes that a number of chemotherapy and targeted agents have now expanded to non-oncology spaces, which includes rheumatoid arthritis, lupus, nephritis, multiple sclerosis, and ectopic pregnancies. Regardless of the setting, these agents still contain harmful and severe side effects. The goal of the project was to develop interdisciplinary standards, which are required to manage the complex processes involved in chemotherapy delivery.

The study developed 16 system wide guidelines based on the 31 combined preexisting ONS and ASCO safety standards. The 16 guidelines promote a multidisciplinary approach to prescribing, ordering, mixing, dispensing, administering, and safe handling of chemotherapy.

Vioral notes it is important to include each entity in the standards because each group plays an important role in ensuring safe chemotherapy delivery.

<<<

View more from the 2012 ONS Congress

Related Videos
Albert Grinshpun, MD, MSc, head, Breast Oncology Service, Shaare Zedek Medical Center
Erica L. Mayer, MD, MPH, director, clinical research, Dana-Farber Cancer Institute; associate professor, medicine, Harvard Medical School
Stephanie Graff, MD, and Chandler Park, FACP
Mariya Rozenblit, MD, assistant professor, medicine (medical oncology), Yale School of Medicine
Maxwell Lloyd, MD, clinical fellow, medicine, Department of Medicine, Beth Israel Deaconess Medical Center
Neil Iyengar, MD, and Chandler Park, MD, FACP
Azka Ali, MD, medical oncologist, Cleveland Clinic Taussig Cancer Institute
Rena Callahan, MD, and Chandler Park, MD, FACP
Hope S. Rugo, MD, FASCO, Winterhof Family Endowed Professor in Breast Cancer, professor, Department of Medicine (Hematology/Oncology), director, Breast Oncology and Clinical Trials Education; medical director, Cancer Infusion Services; the University of California San Francisco Helen Diller Family Comprehensive Cancer Center
Virginia Kaklamani, MD, DSc, professor, medicine, Division of Hematology-Medical Oncology, The University of Texas (UT) Health Science Center San Antonio; leader, breast cancer program, Mays Cancer Center, UT Health San Antonio MD Anderson Cancer Center